- Research article
- Open Access
- Open Peer Review
Intraoperative use of enriched collagen and elastin matrices with freshly isolated adipose-derived stem/stromal cells: a potential clinical approach for soft tissue reconstruction
© Alharbi et al.; licensee BioMed Central Ltd. 2014
- Received: 3 May 2013
- Accepted: 17 February 2014
- Published: 20 February 2014
Adipose tissue contains a large number of multipotent cells, which are essential for stem cell-based therapies. The combination of this therapy with suitable commercial clinically used matrices, such as collagen and elastin matrices (i.e. dermal matrices), is a promising approach for soft tissue reconstruction. We previously demonstrated that the liposuction method affects the adherence behaviour of freshly isolated adipose-derived stem/stromal cells (ASCs) on collagen and elastin matrices. However, it remains unclear whether freshly isolated and uncultured ASCs could be directly transferred to matrices during a single transplantation operation without additional cell culture steps.
After each fat harvesting procedure, ASCs were isolated and directly seeded onto collagen and elastin matrices. Different time intervals (i.e. 1, 3 and 24 h) were investigated to determine the time interval needed for cellular attachment to the collagen and elastin matrices. Resazurin-based vitality assays were performed after seeding the cells onto the collagen and elastin matrices. In addition, the adhesion and migration of ASCs on the collagen and elastin matrices were visualised using histology and two-photon microscopy.
A time-dependent increase in the number of viable ASCs attached to the collagen and elastin matrices was observed. This finding was supported by mitochondrial activity and histology results. Importantly, the ASCs attached and adhered to the collagen and elastin matrices after only 1 h of ex vivo enrichment. This finding was also supported by two-photon microscopy, which revealed the presence and attachment of viable cells on the upper layer of the construct.
Freshly isolated uncultured ASCs can be safely seeded onto collagen and elastin matrices for ex vivo cellular enrichment of these constructs after liposuction. Although we observed a significant number of seeded cells on the matrices after a 3-h enrichment time, we also observed an adequate number of isolated cells after a 1-h enrichment time. However, this approach must be optimised for clinical use. Thus, in vivo studies and clinical trials are needed to investigate the feasibility of this approach.
- Adipose tissue-derived stem/stromal cells
- Stromal vascular fraction
- Fat grafting
- Collagen-based scaffolds
- Regeneration and tissue engineering
Adipose tissue stores a large number of multipotent cells, which are essential for stem cell-based therapies . Stem and progenitor cells typically comprise approximately 3 to 7% of the cells in the uncultured stromal vascular fraction (SVF) from adipose tissue [1, 2]. The term SVF is commonly used in the literature and refers to the cellular pellet without fat cells (i.e., mature adipocytes). This fraction can be obtained through an isolation process that uses collagenase secondary to liposuction (i.e., fat harvesting), resulting in a component that contains multiple cells: adipose-derived stem/stromal cells (ASCs). ASCs consist of endothelial cells, smooth muscle cells, fibroblasts and stem cells. . Adipose-derived stem cells are adult self-renewing cells of mesenchymal origin that can differentiate not only into the adipogenic lineage but also into the osteogenic, chondrogenic, myogenic and neurogenic lineages in vitro[3, 4].
We previously demonstrated that the method of liposuction influences the viability of the ASCs isolated from adipose tissue and the quantity of growth factors produced after cellular transplantation onto clinically used collagen and elastin matrices . The results also indicated that collagen and elastin matrices could be used as ex vivo cellular carriers for tissue engineering. In this context, several studies investigated the safety of collagen and elastin matrices for keratinocyte and ASC cultivation . Tissue engineering protocols that include a specific time period for the cultivation of ASCs require the use of a lab facility for as long as several days. Such protocols require Good Manufacturing Practicing (GMP) facilities and may be expensive. In contrast, the manual or automatic isolation of ASCs can be performed directly in the operating room (e.g., using a Cytori device). Thus, the direct transfer of ASCs onto available commercial matrices would be possible during a single operation. However, a short cultivation time (i.e., 1 to 3 hours) would be ideal for transplantation, particularly in a clinical setting with no access to further lab processing or GMP facilities.
These time intervals were chosen to determine whether a 3-h time period is needed for cellular sedimentation onto the scaffolds or whether a 1-h sedimentation time is adequate for the cells to attach and migrate onto the collagen and elastin matrices prior to transplantation of the enriched construct in the operating room. We compared the results obtained using short cultivation times (1 and 3 h) with the results obtained using a 24-h cellular cultivation time, which was demonstrated to be a successful approach in our previous study . We designed the experiment without the need for processing of the cells to simulate clinical conditions. Thus, for example, a patient could have a single operation that included the enrichment of the selected collagen-based matrix and split thickness skin transfer for multi-layer reconstruction of soft tissue defects.
Ten healthy patients (5 males and 5 females) between 27 and 59 years of age had elective liposuction (i.e., fat harvesting) in the Department of Plastic, Reconstructive and Hand Surgery – Burns Center at RWTH Aachen University Hospital. Each patient signed the consent form. The protocol and the use of human material were approved by the ethics committee of the Faculty of Medicine at RWTH University in Aachen, Germany (Name in German: Ethik-Kommission des Universitätsklinikums Aachen, Votum Number: EK163/07). The experiments were conducted in compliance with the Declaration of Helsinki Principles.
Liposuction and centrifugation of the obtained lipoaspirate
Fat was harvested via tumescent liposuction, as described previously [5, 7]. The harvesting cannula used in this study was the st’RIM cannula (Thiebaud Biomedical Devices, Margencel, France), which was developed by Guy Magalon for micro-lipografting. This cannula was 2 mm in diameter with a blunt tip and four 600-μm gauge orifices. After the liposuction procedure, the samples were centrifuged for 3 min at 3,000 rpm using a Sigma 2–16 K centrifuge (Osterode am Harz, Germany). After centrifugation, the purified lipoaspirate was immediately used in experiments (Figure 1).
Isolation of ASCs from lipoaspirate
Isolation of the cellular pellet was performed as described previously . Briefly, the purified lipoaspirate was transferred into a sterile tube and normal saline was added to remove cell debris and blood. A second centrifugation process was then completed for 10 min at 300 × g. The extracellular matrix was digested with 0.075% collagenase I (Biochrom, Berlin, Germany) for 45 min at 37°C. The digested tissue solution was subsequently filtered using a 250 μm filter (Neolab, Heidelberg, Germany). The pellet was resuspended in 30 ml of a NaCl solution and centrifuged for another 10 min at 300 × g to obtain the SVF, which contained the ASCs. The pellet was then resuspended in DMEM/F12 supplemented with 100 U/ml of penicillin and 100 μg of streptomycin, without foetal calf serum or proliferation factors. The isolated cells were not cultured or passaged prior to direct transplantation onto the collagen and elastin matrix.
Incubation of ASCs on collagen and elastin matrices to assess cellular adherence
Circular 1 mm thick pieces of non–cross-linked native bovine collagen and elastin matrix containing type I, III, and V collagen derived from bovine skin were used (Matriderm® sheet; MedSkin Solutions Dr. Suwelack AG, Billerbeck, Germany). A circular punch biopsy device measuring 0.8 cm in diameter was used to cut the matrix into small pieces, which were placed into 48-well culture plates. The isolated cells were added to 48-well culture plates lined with collagen and elastin matrix at a density of 50,000 cells per well and incubated at 37°C with 5% CO2 for 1, 3 or 24 h. The collagen and elastin matrix that was incubated with the isolated cells was separated after a 1-, 3- or 24-h incubation period (Figure 1). The matrices were washed carefully with normal saline (0.9% NaCl) and transferred into a clean culture Plate. A 270 μl volume of DMEM/F12 supplemented with 100 U/ml penicillin and 100 μg/ml streptomycin was added, and 30 μl of the alamarBlue® resazurin reagent (AbD Serotec, Oxford, UK), was subsequently delivered to each well. This assay can be used to detect the metabolic activity of cells using a fluorescence spectrometer. The medium/alamarBlue® mix was repeated and carefully removed from the well after 2 hours at 37°C and 5% CO2. The samples were then measured at room temperature using a Fluostar Optima fluorescence spectrometer (BMG Labtech, Offenburg, Germany), with an excitation wavelength of 540 nm and an emission wavelength 590 nm. We avoided measuring the matrix itself to avoid the influence of the matrix on fluorescence. The alamarBlue® reagent was added to the medium without cells as a negative control.
Analysis of cellular attachment and migration by histology
Cell-loaded pieces of collagen and elastin matrix were histologically investigated directly after cellular transplantation onto the matrix. The samples were fixed overnight in Lidi’s 4% formalin (Merck, Darmstadt, Germany). The formalin was then removed by extensive washing, and the samples were dehydrated using an increasing gradient of isopropanol, embedded into paraplast, and cut into 15 μm sections. Staining was then performed using hematoxylin and eosin. Microscopic analyses of all samples were performed via light microscopy in our laboratory.
Analysis of cellular distribution on collagen and elastin matrices using two-photon microscopy
Two-photon microscopy using an FV1000MPE microscope (Olympus Corp., Tokyo, Japan) attached to a pulsed Ti-Sapphire laser (MaiTai DeepSee, SpectraPhysics, Santa Clara, CA, USA) was performed to visualise the 3D-structure of the collagen and elastin matrices, including the organisation of the isolated cells within the matrix. Hoechst 33342 was added for vital staining of the nuclei. The enriched collagen and elastin matrices were also stained with fluorescein diacetate (FDA) to image the isolated cells in combination with Hoechst 33342 for nuclei staining. The enriched collagen and elastin matrix was then visualised using the non-linear optical effect of second harmonic generation (SHG). Hoechst was excited at 730 nm and detected at 418–468 nm. Series of subsequent 1024 × 1024 pixel xy-frames were then obtained in 1 mm z-steps for structural 3D reconstruction using Imaris Software (Bitplane, Zurich, Switzerland).
Data analysis was performed using Prism® software, version 5.01c (GraphPad, La Jolla, CA, USA). A Gaussian distribution of the values was assessed using the D’Agostino & Pearson omnibus normality test. One-way repeated measures ANOVA was performed followed by an appropriate post-hoc multiple comparison test (i.e., Tukey method). Differences for which p < 0.05 were considered statistically significant.
Assessment of ASC adherence to collagen and elastin matrices
Analysis of cellular attachment and migration using histology
Visualisation of the 3D structure of collagen and elastin matrices to assess morphology and attachment of seeded ASCs
The clinical applicability of adipose-derived stem cell therapy has been investigated extensively during the last decade, and interesting results have been obtained with respect to regeneration and wound healing, as well as reconstruction and rejuvenation . One advantage of this approach is that adipose tissue represents an easily available and accessible source of mesenchymal stem cells that are supported by abundant stromal cells and growth factors . However, it is essential to determine the applicability of this approach, particularly with respect to legal issues. In some countries, including Germany, any patient materials that leave the operating room for stem cell processing and future re-injection must be processed in GMP facilities. These facilities are expensive and difficult to find. In contrast, autologous transplantation of ASCs in a single session would overcome this problem. Several previous studies investigated the effect of enriching fat grafts with the SVF in a clinical setting . However, it remains unclear whether the enrichment of a safe and biocompatible collagen and elastin matrix with autologous and freshly isolated ASCs is possible. In addition, the role of enrichment time in this approach has not been investigated. Studies addressing these issues could expand the use of soft tissue matrices in combination with ASCs.
Biocompatible matrices, such as collagen and elastin matrices, are currently used in combination with skin grafting as double-layer constructs to support the graft and the formation of a neodermis . However, it must be determined not only whether such matrices are biocompatible but also whether they are cytocompatible. In our previously published study, we demonstrated that freshly isolated uncultured ASCs adhere to collagen and elastin matrices ex vivo in only 24 hours. This result indicates that these biocompatible materials are also cytocompatible and appropriate for use with mesenchymal stem cells immediately after their isolation.
However, a 24-h enrichment time is too long to be implemented in the operating room. Thus, a shorter enrichment time of the selected scaffolds with the stem cells is required. We investigated different time intervals to determine whether a 3-h or 1-h cellular sedimentation time on the scaffolds is sufficient to support cellular attachment and migration onto the collagen and elastin matrices prior to transplantation of the enriched construct in the operating room. We compared the results obtained using these short cultivation times (i.e., 1 and 3 h) with the results obtained using a 24 h cellular cultivation time.
In this study, we observed that cellular enrichment on the collagen and elastin matrices after 3 h is improved compared to that observed after 1 h. These results were supported by mitochondrial activity results, which indicate viability, and histological analysis [10–13]. In addition, we demonstrated that enrichment of a collagen and elastin matrix with cells obtained from adipose tissue is possible after a 1-h ex vivo enrichment time. This conclusion was also supported by two-photon microscopy results, which revealed the presence and attachment of viable cells on the upper layer of the construct. However, penetration depth is limited based on the employed material, tissue or scaffold (e.g., for collagen and elastin matrices up to 150 μm).
Protocols must be defined for clinical use. Such protocols should include the ideal time for cellular enrichment on the selected biocompatible and cytocompatible matrices, the number of isolated adipose cells per square meter, the proportions of specific cellular elements, including stem cells, in the total population, the commitment of those stem cells toward adipogenic conversion or conversion into other lines in vivo and the factors important for control of the environment, including factors that support nutrition and angiogenesis. These factors must be investigated in animal models before this type of therapy can be applied in a clinical setting. The fate of ASC-enriched collagen and elastin matrices after transplantation can only be determined in vivo in clinical trials. However, prior to clinical trials, it is also necessary to optimise this approach. Specifically, the type of isolated cells that adhere to the matrix must be characterised. The regenerative potential of these cells and the potential benefits for patients should also be addressed in future studies. As previously discussed, the use of the freshly isolated uncultured ASCs seeded directly onto biocompatible scaffolds during a single surgery avoids the need for GMP facilities. Thus, this approach would bridge the gap between the bench and the bedside.
Freshly isolated uncultured ASCs can be safely seeded onto collagen and elastin matrices after a liposuction procedure for ex vivo cellular enrichment of these constructs. Although we observed a significant number of transplanted cells on the matrices after a 3-h enrichment time, we could also observed an adequate number of isolated cells on the matrices after a shorter 1-h enrichment time. This finding was also supported by two-photon microscopy. However, it is necessary to optimise this approach for clinical use. Thus, in vivo studies and clinical trials are needed to investigate the feasibility of this approach.
We thank MedSkin Solutions Dr. Suwelack AG in Billerbeck, Germany for supplying the Matriderm® sheets. This work was also supported by the two-photon microscopy facility, which is a core facility of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University. We acknowledge the American Manuscript Editors for their extensive editing service of this manuscript. Finally, all authors acknowledge Prof. Hilgers and his team in the department of medical statistics at RWTH Aachen University for the revision of our statistical analysis.
- Fraser JK, Zhu M, Wulur I, Alfonso Z: Adipose-derived stem cells. Methods Mol Biol. 2008, 449: 59-67.PubMedGoogle Scholar
- Tholpady SS, Llull R, Ogle RC, Rubin JP, Futrell JW, Katz AJ: Adipose tissue: stem cells and beyond. Clin Plast Surg. 2006, 33 (1): 55-62. 10.1016/j.cps.2005.08.004.View ArticlePubMedGoogle Scholar
- Mizuno H: Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nihon Med Sch. 2009, 76 (2): 56-66. 10.1272/jnms.76.56.View ArticleGoogle Scholar
- Gimble JM: Adipose tissue-derived therapeutics. Expert Opin Biol Ther. 2003, 3: 705-713. 10.1517/147125188.8.131.525.View ArticlePubMedGoogle Scholar
- Alharbi Z, Opländer C, Almakadi S, Fritz A, Vogt M, Pallua N: Conventional vs. micro-fat harvesting: how fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells. J Plast Reconstr Aesthet Surg. 2013, 66 (9): 1271-1278. 10.1016/j.bjps.2013.04.015.View ArticlePubMedGoogle Scholar
- Keck M, Haluza D, Lumenta DB, Burjak S, Eisenbock B, Kamolz LP, Frey M: Construction of a multi-layer skin substitute: Simultaneous cultivation of keratinocytes and preadipocytes on a dermal template. Burns. 2011, 37 (4): 626-630. 10.1016/j.burns.2010.07.016.View ArticlePubMedGoogle Scholar
- Coleman SR: Structural fat grafts: the ideal filler?. Clin Plast Surg. 2001, 28: 111-119.PubMedGoogle Scholar
- Chang Q, Li J, Dong Z, Liu L, Lu F: Quantitative volumetric analysis of progressive hemifacial atrophy corrected using stromal vascular fraction-supplemented autologous fat grafts. Dermatol Surg. 2013, 39 (10): 1465-1473.PubMedGoogle Scholar
- Jeon H, Kim J, Yeo H, Jeong H, Son D, Han K: Treatment of diabetic foot ulcer using matriderm in comparison with a skin graft. Arch Plast Surg. 2013, 40 (4): 403-408. 10.5999/aps.2013.40.4.403.View ArticlePubMedPubMed CentralGoogle Scholar
- Walum E, Hansson E, Harvey AL: In vitro testing of neurotoxicity. ATLA. 1990, 18: 153-179.Google Scholar
- Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J: Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: Visual results and histopathological findings. Br J Ophthalmol. 2003, 87: 216-219. 10.1136/bjo.87.2.216.View ArticlePubMedPubMed CentralGoogle Scholar
- Ahmed SA, Gogal RM, Walsh JE: A new Rapid and Simple Non-Radioactive assay to Monitor and Determine the proliferation of Lymphocytes: An Alternative to H3-thymidine incorporation assay. J lmmunol Methods. 1994, 170: 211-224. 10.1016/0022-1759(94)90396-4.View ArticleGoogle Scholar
- Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay. Cancer Res. 1988, 48: 589-601.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/14/10/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.